B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells

Journal of Immunology

Volumn 185, Issue 7, 2010, Pages 3970-3979

  Dianzani, Chiara ^a   Minelli, Rosalba ^a   Mesturini, Riccardo ^b   Chiocchetti, Annalisa ^b   Barrera, Giuseppina ^a   Boscolo, Sabrina ^c   Sarasso, Chiara ^b   Gigliotti, Casimiro Luca ^b   Sblattero, Daniele ^b   Yagi, Junji ^d   Rojo, Josè Maria ^e   Fantozzi, Roberto ^a   Dianzani, Umberto ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ICOS T CELL COSTIMULATORY MOLECULE; IMMUNOLOGIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY; MUTANT PROTEIN; OSTEOPONTIN; UNCLASSIFIED DRUG; CD274 PROTEIN, HUMAN; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; METASTASIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PHYSIOLOGY; SIGNAL TRANSDUCTION; UMBILICAL CORD; WESTERN BLOTTING;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BLOTTING, WESTERN; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; ENDOTHELIAL CELLS; HUMANS; NEUTROPHILS; SIGNAL TRANSDUCTION; UMBILICAL CORD;

EID: 77958137498     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903269     Document Type: Article

References (35)

1. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-689.
2. Laferrière, J., F. Houle, M. M. Taher, K. Valerie, and J. Huot. 2001. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J. Biol. Chem. 276:33762-33772.
3. Laferrière, J., F. Houle, and J. Huot. 2004. Adhesion of HT-29 colon carcinoma cells to endothelial cells requires sequential events involving E-selectin and integrin beta4. Clin. Exp. Metastasis 21:257-264.
4. Zeisig, R., R. Stahn, K. Wenzel, D. Behrens, and I. Fichtner. 2004. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro. Biochim. Biophys. Acta 1660:31-40.
5. Inman, B. A., X. Frigola, H. Dong, and E. D. Kwon. 2007. Costimulation, coinhibition and cancer. Curr. Cancer Drug Targets 7:15-30.
6. Rushworth, S. A., C. A. Bravery, and S. Thompson. 2001. Human CD154 induces activation of porcine endothelial cells and up-regulation of MHC class II expression. Transplantation 72:127-132.
7. Swallow, M. M., J. J. Wallin, and W. C. Sha. 1999. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha. Immunity 11:423-432.
8. Khayyamian, S., A. Hutloff, K. Büchner, M. Gräfe, V. Henn, R. A. Kroczek, and H. W. Mages. 2002. ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cells. Proc. Natl. Acad. Sci. USA 99:6198-6203.
9. Hutloff, A., A. M. Dittrich, K. C. Beier, B. Eljaschewitsch, R. Kraft, I. Anagnostopoulos, and R. A. Kroczek. 1999. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397:263-266.
10. Nurieva, R. I. 2005. Regulation of immune and autoimmune responses by ICOS-B7h interaction. Clin. Immunol. 115:19-25.
11. Dong, C., A. E. Juedes, U. A. Temann, S. Shresta, J. P. Allison, N. H. Ruddle, and R. A. Flavell. 2001. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 409:97-101.
12. Tafuri, A., A. Shahinian, F. Bladt, S. K. Yoshinaga, M. Jordana, A. Wakeham, L. M. Boucher, D. Bouchard, V. S. Chan, G. Duncan, et al. 2001. ICOS is essential for effective T-helper-cell responses. Nature 409:105-109.
13. McAdam, A. J., R. J. Greenwald, M. A. Levin, T. Chernova, N. Malenkovich, V. Ling, G. J. Freeman, and A. H. Sharpe. 2001. ICOS is critical for CD40-mediated antibody class switching. Nature 409:102-105.
14. Mesturini, R., S. Nicola, A. Chiocchetti, I. S. Bernardone, L. Castelli, T. Bensi, M. Ferretti, C. Comi, C. Dong, J. M. Rojo, et al. 2006. ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells. Eur. J. Immunol. 36:2601-2612.
15. Di Niro, R., F. Ziller, F. Florian, S. Crovella, M. Stebel, M. Bestagno, O. Burrone, A. R. Bradbury, P. Secco, R. Marzari, and D. Sblattero. 2007. Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. BMC Biotechnol. 7:46.
16. Dianzani, C., L. Brucato, M. Gallicchio, A. C. Rosa, M. Collino, and R. Fantozzi. 2008. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Br. J. Pharmacol. 153:1153-1161.
17. Dianzani, C., M. Collino, G. Lombardi, G. Garbarino, and R. Fantozzi. 2003. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br. J. Pharmacol. 139:1103-1110.
18. Burbridge, M. F., V. Venot, P. J. Casara, F. Perron-Sierra, J. A. Hickman, and G. C. Tucker. 2003. Decrease in survival threshold of quiescent colon carcinoma cells in the presence of a small molecule integrin antagonist. Mol. Pharmacol. 63:1281-1288.
19. Dexter, D. L., J. A. Barbosa, and P. Calabresi. 1979. N, N-dimethylformamideinduced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 39:1020-1025.
20. Wang, S., G. Zhu, K. Tamada, L. Chen, and J. Bajorath. 2002. Ligand binding sites of inducible costimulator and high avidity mutants with improved function. J. Exp. Med. 195:1033-1041.
21. Tremblay, P. L., F. A. Auger, and J. Huot. 2006. Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 25:6563-6573.
22. Bevilacqua, M. P., J. S. Pober, D. L. Mendrick, R. S. Cotran, and M. A. Gimbrone, Jr. 1987. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84:9238-9242.
23. Whelan, J., P. Ghersa, R. Hooft van Huijsduijnen, J. Gray, G. Chandra, F. Talabot, and J. F. DeLamarter. 1991. An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 19:2645-2653.
24. Rodriguez, E., J. Guevara, A. Paez, E. Zapata, M. T. Collados, T. I. Fortoul, R. Lopez-Marure, F. Masso, and L. F. Montaño. 2008. The altered expression of inflammation-related molecules and secretion of IL-6 and IL-8 by HUVEC from newborns with maternal inactive systemic lupus erythematosus is modified by estrogens. Lupus 17:1086-1095.
25. Cheng, Q., S. J. McKeown, L. Santos, F. S. Santiago, L. M. Khachigian, E. F. Morand, and M. J. Hickey. 2010. Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules. J. Immunol. 185:1238-1247.
26. Dai, J., L. Peng, K. Fan, H. Wang, R. Wei, G. Ji, J. Cai, B. Lu, B. Li, D. Zhang, et al. 2009. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 28:3412-3422.
27. Montiel, M., E. P. De La Blanca, and E. Jiménez. 2006. P2Y receptors activate MAPK/ERK through a pathway involving PI3K/PDK1/PKC-zeta in human vein endothelial cells. Cell. Physiol. Biochem. 18:123-134.
28. Barreiro, O., H. De La Fuente, M. Mittelbrunn, and F. Sánchez-Madrid. 2007. Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions. Immunol. Rev. 218:147-164.
29. Barreiro, O., M. Yáñez-Mó, M. Sala-Valdés, M. D. Gutiérrez-López, S. Ovalle, A. Higginbottom, P. N. Monk, C. Cabañas, and F. Sánchez-Madrid. 2005. Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation. Blood 105:2852-2861.
30. Hu, Y., J. M. Kiely, B. E. Szente, A. Rosenzweig, and M. A. Gimbrone, Jr. 2000. E-selectin-dependent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells. J. Immunol. 165:2142-2148.
31. Gout, S., P. L. Tremblay, and J. Huot. 2008. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin. Exp. Metastasis 25:335-344.
32. Kiely, J. M., Y. Hu, G. García-Cardeña, and M. A. Gimbrone, Jr. 2003. Lipid raft localization of cell surface E-selectin is required for ligation-induced activation of phospholipase C gamma. J. Immunol. 171:3216-3224.
33. McEver, R. P. 1997. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj. J. 14:585-591.
34. Blankenberg, S., S. Barbaux, and L. Tiret. 2003. Adhesion molecules and atherosclerosis. Atherosclerosis 170:191-203.
35. Logue, E. C., S. Bakkour, M. M. Murphy, H. Nolla, and W. C. Sha. 2006. ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9. J. Immunol. 177:2356-2364.